Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis Patients
NCT03724188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2024-06-25
Summary
The aim of this study is to assess the clinical, laboratory and vascular calcification outcome within 6 months duration in patients undergoing surgical parathyroidectomy (total, subtotal, and total with autotransplantation)
Conditions
- Hyperparathyroidism, Secondary
Interventions
- PROCEDURE
-
surgical parathyroidectomy
total parathyroidectomy, subtotal parathyroidectomy, total parathyroidectomy with autotransplantation
Sponsors & Collaborators
-
Mansoura General Hospital
lead OTHER
Principal Investigators
-
Tarek M Abbas, PhD · Institutional Research Board MFM
-
Ahmed M Halawa, PhD · Institutional Research Board MFM
-
. Donia M Sobh · Institutional Research Board MFM
-
Nagy S Abd-elhady, PhD · Institutional Research Board MFM
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-30
- Primary Completion
- 2021-10-30
- Completion
- 2021-10-30
Countries
- Egypt
Study Locations
More Related Trials
-
FGF-23 and PTH in Hemodialysis Patients
NCT04350944 ·Status: COMPLETED
-
Parathyroidectomy in Endstage Renal Disease
NCT00745719 ·Status: COMPLETED ·Phase: NA
-
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
NCT00469599 ·Status: TERMINATED ·Phase: NA
-
Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital
NCT04967469 ·Status: COMPLETED ·Phase: NA
-
Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302 ·Status: COMPLETED ·Phase: PHASE2
-
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
NCT04750460 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.
NCT02895061 ·Status: COMPLETED ·Phase: NA
-
the Study on Prognostic for Hemodialysis Patients
NCT03194087 ·Status: UNKNOWN
-
The Effect of Exercise on Blood Parameters Related to Dialysis Patients' Survival
NCT04916743 ·Status: COMPLETED ·Phase: NA
-
Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
NCT03182517 ·Status: UNKNOWN
-
The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
NCT03082742 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Etelcalcetide on CKD-MBD
NCT03960437 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Parathyroidectomy on Renal Function
NCT04798092 ·Status: UNKNOWN
-
The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD
NCT06398002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
NCT00537979 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
NCT01748396 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
NCT02332135 ·Status: UNKNOWN ·Phase: NA
-
Tissue-nonspecific Alkaline Phosphatase in Phosphate and Pyrophosphate Homeostasis.
NCT03520738 ·Status: COMPLETED ·Phase: NA
-
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
NCT00995163 ·Status: COMPLETED
-
Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
NCT01341782 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
NCT00664430 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients
NCT03182699 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
NCT02684643 ·Status: COMPLETED ·Phase: NA
-
Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients
NCT00477516 ·Status: COMPLETED ·Phase: NA
-
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
NCT00297219 ·Status: COMPLETED ·Phase: NA